ArticleEJVES vascular forum2025
Trends in Management and Outcomes of Blunt Thoracic Aortic Injury in the United States.
Article in EJVES vascular forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Traumatic aortic isthmus transection with pseudoaneurysm formation and massive mediastinal hematoma: management challenges in resource-limited countries: case report.Journal of cardiothoracic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Blunt thoracic aortic injury (BTAI) is a significant cause of mortality and morbidity in the United States. The diagnosis and treatment of BTAI has evolved over the last few decades. This study aimed to examine the incidence and outcomes of thoracic endovascular aortic repair (TEVAR), non-operative management (NOM), and open aortic repair (OAR) for BTAI over a 14 year period. Methods: Patients with BTAI from the National Inpatient Sample between 2006 - 2019 were studied and compared within three time periods: 2006-2010, 2011-2015, and 2016-2019. Waldtest and Pearson's chi-squared were performed to test whether management, patient characteristics, and in hospital mortality changed over time. Results: An estimate of 8 175 BTAI patients was identified, with an increasing estimate from 375 patients in 2006 to 750 patients in 2019. TEVAR utilisation increased from 17% to 37% during the study period, while those who received OAR and NOM decreased (OAR 16%-1.3%; NOM 67%-61%). There was an increasing trend in patients treated in an urban teaching hospital (2006-2010 Conclusion: The estimated number of patients with BTAI was twice as large in 2019 compared with 2006, and the use of TEVAR increased, largely replacing OAR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.